Global Biopharmaceutical Company - Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Bristol Myers Squibb - Wikipedia
The Squibb corporation was founded in 1858 by Edward Robinson Squibb in Brooklyn, New York. [8][9] Squibb was known as an advocate of quality control and high purity standards early …
Bristol Myers Squibb Announces Agreement with U.S
Dec 19, 2025 · Bristol Myers Squibb (NYSE: BMY, “BMS”) today announced an agreement with the U.S. government to provide Eliquis® (apixaban), an oral anticoagulant relied upon by …
Bristol-Myers Squibb Company - Encyclopedia Britannica
Dec 19, 2025 · Bristol-Myers Squibb Company, American biopharmaceutical company resulting from a merger in 1989 and dating to companies founded in 1858 and 1887. It produces …
June Squibb Reflects on Returning to Broadway 66 Years After …
Sep 27, 2025 · June Squibb is reflecting on returning to Broadway 66 years after making her debut in 'Gypsy.' The 95-year-old actress will star in 'Marjorie Prime,' which is set to open at …
Bristol-Myers Squibb: Pharma Giant Undervalued, Printing Cash …
6 days ago · Bristol-Myers Squibb Company is rated a Buy with solid rebound and robust free cash flow margins. Learn more about BMY stock here.
JP Morgan 2026 Preview: Bristol Myers Squibb’s Continued Growth
6 days ago · Bristol Myers Squibb (BMS) has yet to announce official presentation plans at the 44 th annual JP Morgan Healthcare Conference, although Karin Shanahan, EVP, chief supply …
BMS Joins the In Vivo Cell Therapy Chase With $1.5B Orbital ...
Oct 13, 2025 · Startup Orbital Therapeutics brings Bristol Myers Squibb an in vivo cell therapy in development for treating autoimmune disease. With the deal, BMS joins AstraZeneca, AbbVie, …
FDA approves Bristol Myers Squibb's schizophrenia drug - CNBC
Sep 26, 2024 · Bristol Myers Squibb expects the twice-daily pill, which will be sold under the brand name Cobenfy, to be available in late October, executives told CNBC.
More Drugmakers Reach Deals With White House to Lower Prices
Dec 19, 2025 · Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay, in a …